- Home
- AIR vs SLNO Comparison
AIR vs SLNO Comparison
Compare AIR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIR
- SLNO
- Stock Information
- Founded
- AIR 1951
- SLNO 1999
- Country
- AIR United States
- SLNO United States
- Employees
- AIR N/A
- SLNO N/A
- Industry
- AIR Aerospace
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AIR Industrials
- SLNO Health Care
- Exchange
- AIR Nasdaq
- SLNO Nasdaq
- Market Cap
- AIR 2.3B
- SLNO 2.2B
- IPO Year
- AIR 1988
- SLNO 2014
- Fundamental
- Price
- AIR $61.81
- SLNO $46.13
- Analyst Decision
- AIR Strong Buy
- SLNO Strong Buy
- Analyst Count
- AIR 4
- SLNO 5
- Target Price
- AIR $81.50
- SLNO $71.20
- AVG Volume (30 Days)
- AIR 173.3K
- SLNO 400.5K
- Earning Date
- AIR 03-20-2025
- SLNO 03-05-2025
- Dividend Yield
- AIR N/A
- SLNO N/A
- EPS Growth
- AIR N/A
- SLNO N/A
- EPS
- AIR 0.28
- SLNO N/A
- Revenue
- AIR $2,571,600,000.00
- SLNO N/A
- Revenue This Year
- AIR $19.84
- SLNO N/A
- Revenue Next Year
- AIR $6.37
- SLNO N/A
- P/E Ratio
- AIR $217.64
- SLNO N/A
- Revenue Growth
- AIR 18.53
- SLNO N/A
- 52 Week Low
- AIR $54.71
- SLNO $36.61
- 52 Week High
- AIR $76.34
- SLNO $60.92
- Technical
- Relative Strength Index (RSI)
- AIR 30.31
- SLNO 40.51
- Support Level
- AIR $64.36
- SLNO $48.48
- Resistance Level
- AIR $65.42
- SLNO $52.46
- Average True Range (ATR)
- AIR 1.63
- SLNO 2.07
- MACD
- AIR -0.75
- SLNO -0.47
- Stochastic Oscillator
- AIR 0.88
- SLNO 0.94
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.